77 related articles for article (PubMed ID: 35627249)
21. Multiple endocrine neoplasia type 2: A review.
Mathiesen JS; Effraimidis G; Rossing M; Rasmussen ÅK; Hoejberg L; Bastholt L; Godballe C; Oturai P; Feldt-Rasmussen U
Semin Cancer Biol; 2022 Feb; 79():163-179. PubMed ID: 33812987
[TBL] [Abstract][Full Text] [Related]
22. Pheochromocytoma and Paraganglioma.
Neumann HPH; Young WF; Eng C
N Engl J Med; 2019 Aug; 381(6):552-565. PubMed ID: 31390501
[No Abstract] [Full Text] [Related]
23. Structure and mechanism of the cation-chloride cotransporter NKCC1.
Chew TA; Orlando BJ; Zhang J; Latorraca NR; Wang A; Hollingsworth SA; Chen DH; Dror RO; Liao M; Feng L
Nature; 2019 Aug; 572(7770):488-492. PubMed ID: 31367042
[TBL] [Abstract][Full Text] [Related]
24. 65 YEARS OF THE DOUBLE HELIX: Genetics informs precision practice in the diagnosis and management of pheochromocytoma.
Neumann HP; Young WF; Krauss T; Bayley JP; Schiavi F; Opocher G; Boedeker CC; Tirosh A; Castinetti F; Ruf J; Beltsevich D; Walz M; Groeben HT; von Dobschuetz E; Gimm O; Wohllk N; Pfeifer M; Lourenço DM; Peczkowska M; Patocs A; Ngeow J; Makay Ö; Shah NS; Tischler A; Leijon H; Pennelli G; Villar Gómez de Las Heras K; Links TP; Bausch B; Eng C
Endocr Relat Cancer; 2018 Aug; 25(8):T201-T219. PubMed ID: 29794110
[TBL] [Abstract][Full Text] [Related]
25. The penetrance of MEN2 pheochromocytoma is not only determined by
Castinetti F; Maia AL; Peczkowska M; Barontini M; Hasse-Lazar K; Links TP; Toledo RA; Dvorakova S; Mian C; Bugalho MJ; Zovato S; Alevizaki M; Kvachenyuk A; Bausch B; Loli P; Bergmann SR; Patocs A; Pfeifer M; Costa JB; von Dobschuetz E; Letizia C; Valk G; Barczynski M; Czetwertynska M; Plukker JTM; Sartorato P; Zelinka T; Vlcek P; Yaremchuk S; Weryha G; Canu L; Wohllk N; Sebag F; Walz MK; Eng C; Neumann HPH
Endocr Relat Cancer; 2017 Aug; 24(8):L63-L67. PubMed ID: 28649091
[No Abstract] [Full Text] [Related]
26. Phaeochromocytoma in multiple endocrine neoplasia type 2: RET codon-specific penetrance and changes in management during the last four decades.
Mucha L; Leidig-Bruckner G; Frank-Raue K; Bruckner T; Kroiss M; Raue F;
Clin Endocrinol (Oxf); 2017 Oct; 87(4):320-326. PubMed ID: 28605116
[TBL] [Abstract][Full Text] [Related]
27. Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Blanchard A; Bockenhauer D; Bolignano D; Calò LA; Cosyns E; Devuyst O; Ellison DH; Karet Frankl FE; Knoers NV; Konrad M; Lin SH; Vargas-Poussou R
Kidney Int; 2017 Jan; 91(1):24-33. PubMed ID: 28003083
[TBL] [Abstract][Full Text] [Related]
28. M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity.
Jagadeesh KA; Wenger AM; Berger MJ; Guturu H; Stenson PD; Cooper DN; Bernstein JA; Bejerano G
Nat Genet; 2016 Dec; 48(12):1581-1586. PubMed ID: 27776117
[TBL] [Abstract][Full Text] [Related]
29. Bilateral Pheochromocytomas in MEN2A Syndrome: A Two-Institution Experience.
Lang BH; Yu HW; Lo CY; Lee KE; Garcia-Barcelo MM; Woo YC; Lee PC; Wong KP; Tam PK; Lam KS
World J Surg; 2015 Oct; 39(10):2484-91. PubMed ID: 26071011
[TBL] [Abstract][Full Text] [Related]
30. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Wells SA; Asa SL; Dralle H; Elisei R; Evans DB; Gagel RF; Lee N; Machens A; Moley JF; Pacini F; Raue F; Frank-Raue K; Robinson B; Rosenthal MS; Santoro M; Schlumberger M; Shah M; Waguespack SG;
Thyroid; 2015 Jun; 25(6):567-610. PubMed ID: 25810047
[TBL] [Abstract][Full Text] [Related]
31. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Richards S; Aziz N; Bale S; Bick D; Das S; Gastier-Foster J; Grody WW; Hegde M; Lyon E; Spector E; Voelkerding K; Rehm HL;
Genet Med; 2015 May; 17(5):405-24. PubMed ID: 25741868
[TBL] [Abstract][Full Text] [Related]
32. A pedigree analysis of two homozygous mutant Gitelman syndrome cases.
Luo J; Yang X; Liang J; Li W
Endocr J; 2015; 62(1):29-36. PubMed ID: 25273610
[TBL] [Abstract][Full Text] [Related]
33. Comparative Protein Structure Modeling Using MODELLER.
Webb B; Sali A
Curr Protoc Bioinformatics; 2014 Sep; 47():5.6.1-32. PubMed ID: 25199792
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study.
Castinetti F; Qi XP; Walz MK; Maia AL; Sansó G; Peczkowska M; Hasse-Lazar K; Links TP; Dvorakova S; Toledo RA; Mian C; Bugalho MJ; Wohllk N; Kollyukh O; Canu L; Loli P; Bergmann SR; Biarnes Costa J; Makay O; Patocs A; Pfeifer M; Shah NS; Cuny T; Brauckhoff M; Bausch B; von Dobschuetz E; Letizia C; Barczynski M; Alevizaki MK; Czetwertynska M; Ugurlu MU; Valk G; Plukker JT; Sartorato P; Siqueira DR; Barontini M; Szperl M; Jarzab B; Verbeek HH; Zelinka T; Vlcek P; Toledo SP; Coutinho FL; Mannelli M; Recasens M; Demarquet L; Petramala L; Yaremchuk S; Zabolotnyi D; Schiavi F; Opocher G; Racz K; Januszewicz A; Weryha G; Henry JF; Brue T; Conte-Devolx B; Eng C; Neumann HP
Lancet Oncol; 2014 May; 15(6):648-55. PubMed ID: 24745698
[TBL] [Abstract][Full Text] [Related]
35. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.
Krampitz GW; Norton JA
Cancer; 2014 Jul; 120(13):1920-31. PubMed ID: 24699901
[TBL] [Abstract][Full Text] [Related]
36. Role of RET genetic variants in MEN2-associated pheochromocytoma.
Siqueira DR; Ceolin L; Ferreira CV; Romitti M; Maia SC; Maciel LM; Maia AL
Eur J Endocrinol; 2014 Jun; 170(6):821-8. PubMed ID: 24616415
[TBL] [Abstract][Full Text] [Related]
37. High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients.
Imai T; Uchino S; Okamoto T; Suzuki S; Kosugi S; Kikumori T; Sakurai A;
Eur J Endocrinol; 2013 May; 168(5):683-7. PubMed ID: 23416954
[TBL] [Abstract][Full Text] [Related]
38. A framework for variation discovery and genotyping using next-generation DNA sequencing data.
DePristo MA; Banks E; Poplin R; Garimella KV; Maguire JR; Hartl C; Philippakis AA; del Angel G; Rivas MA; Hanna M; McKenna A; Fennell TJ; Kernytsky AM; Sivachenko AY; Cibulskis K; Gabriel SB; Altshuler D; Daly MJ
Nat Genet; 2011 May; 43(5):491-8. PubMed ID: 21478889
[TBL] [Abstract][Full Text] [Related]
39. Spectrum of mutations in Gitelman syndrome.
Vargas-Poussou R; Dahan K; Kahila D; Venisse A; Riveira-Munoz E; Debaix H; Grisart B; Bridoux F; Unwin R; Moulin B; Haymann JP; Vantyghem MC; Rigothier C; Dussol B; Godin M; Nivet H; Dubourg L; Tack I; Gimenez-Roqueplo AP; Houillier P; Blanchard A; Devuyst O; Jeunemaitre X
J Am Soc Nephrol; 2011 Apr; 22(4):693-703. PubMed ID: 21415153
[TBL] [Abstract][Full Text] [Related]
40. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.
McKenna A; Hanna M; Banks E; Sivachenko A; Cibulskis K; Kernytsky A; Garimella K; Altshuler D; Gabriel S; Daly M; DePristo MA
Genome Res; 2010 Sep; 20(9):1297-303. PubMed ID: 20644199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
